Comprehensive Vaginitis qPCR Panel

Comprehensive Vaginitis qPCR Panel 

Vaginitis Overview 

Bacterial or Candida-based vaginal infections are among the most common reasons women in the United States seek medical care. Statistics show that up to 75% of women will experience some form of vaginal infection during their lifetime, resulting in approximately 10 million physician office visits annually (references 1 to 4). Despite this prevalence, around 40% of women with vaginitis leave their initial medical appointment without a clear diagnosis (reference 7). 

Vaginitis is primarily caused by an imbalance between protective Lactobacilli and pathogenic organisms, such as aerobic bacteria, bacterial vaginosis pathogens, and Candida species. Traditional diagnostic techniques—often microscopic—are subjective and have variable sensitivity and specificity. These limitations make it difficult to detect mixed infections accurately, potentially leading to unresolved symptoms, repeated visits, misdiagnoses, inappropriate treatments, and unnecessary healthcare costs. 

Advantages of the Vaginitis qPCR Panel 

The Vaginitis qPCR Panel uses a highly sensitive real-time polymerase chain reaction (PCR) assay to detect the three most common infectious pathogens and 43 antibiotic resistance (ABR) genes related to vaginitis: 

This molecular test provides more precise results than traditional methods and enables clinicians to diagnose accurately even in cases involving mixed infections. The panel supports efficient patient care by allowing one-collection/one-test diagnosis of the most frequent vaginal infections. 

In addition to pathogen identification, the panel also supports antimicrobial stewardship by reporting relevant antibiotic resistance genes. It accommodates multiple specimen types, including urine and female endocervical/vaginal swabs, and utilizes real-time PCR for fast and reliable results. 

The Panel Includes 

Bacteria 

Fungi & Protozoa 

Viruses 

Antibiotic Resistance Genes (ABRs) – 43 Markers